Tokyo, Sept. 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062890) titled 'Biomarker research on interstitial pneumonia using stored serum' on Sept. 11.

Study Type: Observational

Primary Sponsor: Institute - Shinshu University

Condition: Condition - interstitial pneumonia Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - This study aims to prospectively investigate whether measuring the candidate biomarker is useful in predicting the diagnosis of the DAD pattern in patients diagnosed with various interstitial pneumonias, including those with the DAD pattern, as well as infections that pose a diagnostic challenge to distinguish from interstitial pneumonia, congestive heart failure, carcinomatous lymphangitis, and acute respiratory distress syndrome. Furthermore, based on the obtained biomarker results, we aim to utilize them in the development of diagnostic reagents for interstitial pneumonia by Tosoh Corporation. Basic objectives2 - Efficacy

Eligibility: Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - Individuals aged 18 or older who meet any of the following criteria and do not meet any of the exclusion criteria: 1. Individuals diagnosed with interstitial pneumonia 2. Individuals diagnosed with respiratory infections 3. Individuals diagnosed with congestive heart failure 4. Individuals diagnosed with carcinomatous lymphangitis 5. Individuals diagnosed with acute respiratory distress syndrome Key exclusion criteria - 1. Individuals who show neither new shadows nor exacerbation of existing shadows on chest imaging. 2. Individuals who do not undergo blood tests during hospitalization. 3. Individuals who do not show any worsening of their condition, such as requiring hospitalization for diagnostic tests. 4. Individuals who do not undergo chest CT scans during their stay. 5. Individuals who do not have the necessary residual serum. 6. Individuals who cannot secure the required amount of residual serum. 7. Individuals whom the principal investigator deems unsuitable as subjects. Target Size - 50

Recruitment Status: Recruitment status - Open public recruiting Date of protocol fixation - 2026 Year 09 Month 11 Day Date of IRB - 2026 Year 09 Month 10 Day Anticipated trial start date - 2026 Year 09 Month 11 Day Last follow-up date - 2029 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072010

Disclaimer: Curated by HT Syndication.